Filing Details

Accession Number:
0001209191-18-005286
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-24 20:20:15
Reporting Period:
2018-01-22
Accepted Time:
2018-01-24 20:20:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1021412 W Jack Schuler 12544 High Bluff Drive, Suite 200
San Diego CA 92130
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-01-22 12,000 $48.50 3,414,053 No 4 S Indirect Trust & Other
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Trust & Other
Footnotes
  1. The weighted average sale price for these transactions was $48.5026 per share, with a range of $48.00 to $49.02. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
  2. The shares reported on this Form 4 as indirectly owned by the Reporting Person include 3,119,053 shares held indirectly by the Reporting Person's Trust, 65,000 shares held indirectly by the Reporting Person's spouse, and 230,000 shares held by The Schuler Grandchildren's LLC.
  3. In addition to the shares reported on this Form 4 as indirectly owned by the Reporting Person, 946,428 shares are held indirectly by the Schuler Family Foundation and 484,516 shares are held indirectly by trusts for the benefit of the Reporting Person's children. The Reporting Person disclaims all beneficial ownership of the shares owned by the Foundation and the trusts for the benefit of his children, except to the extent of his pecuniary interest, if any.